tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TCRX Stock Latest News

TScan Therapeutics appoints Camiolo as SVP, Market Access
The FlyTScan Therapeutics appoints Camiolo as SVP, Market Access
1M ago
TCRX
TScan Therapeutics assumed with an Overweight at Morgan Stanley
PremiumThe Fly
TScan Therapeutics assumed with an Overweight at Morgan Stanley
1M ago
TCRX
TScan Therapeutics: Promising Advances in TCR-Engineered Cancer Therapies Justify Buy Rating
PremiumRatings
TScan Therapeutics: Promising Advances in TCR-Engineered Cancer Therapies Justify Buy Rating
1M ago
TCRX
Positive Buy Rating for TScan Therapeutics Driven by Promising Clinical Data and Strong Financial Position
PremiumRatings
Positive Buy Rating for TScan Therapeutics Driven by Promising Clinical Data and Strong Financial Position
1M ago
TCRX
TScan Therapeutics price target lowered to $3 from $14 at Barclays
PremiumThe Fly
TScan Therapeutics price target lowered to $3 from $14 at Barclays
2M ago
TCRX
Positive Outlook for TScan Therapeutics: Buy Rating Affirmed Due to Promising TCR-T Cell Therapy Progress and Solid Financial Position
PremiumRatingsPositive Outlook for TScan Therapeutics: Buy Rating Affirmed Due to Promising TCR-T Cell Therapy Progress and Solid Financial Position
2M ago
TCRX
Promising Clinical Differentiation and Strategic Advancements Drive Buy Rating for TScan Therapeutics
Premium
Ratings
Promising Clinical Differentiation and Strategic Advancements Drive Buy Rating for TScan Therapeutics
2M ago
TCRX
Promising Progress and Strategic Expansion Position TScan Therapeutics for Success
Premium
Ratings
Promising Progress and Strategic Expansion Position TScan Therapeutics for Success
2M ago
TCRX
TScan Therapeutics Reports 2024 Financial Results and Progress
PremiumCompany Announcements
TScan Therapeutics Reports 2024 Financial Results and Progress
2M ago
TCRX
TScan Therapeutics files $300M mixed securities shelf
PremiumThe Fly
TScan Therapeutics files $300M mixed securities shelf
2M ago
TCRX
TScan Therapeutics: Buy Rating Affirmed Amid Promising Growth Prospects and Strong Financial Position
PremiumRatings
TScan Therapeutics: Buy Rating Affirmed Amid Promising Growth Prospects and Strong Financial Position
2M ago
TCRX
TScan Therapeutics reports Q4 EPS (30c), consensus (28c)
PremiumThe Fly
TScan Therapeutics reports Q4 EPS (30c), consensus (28c)
2M ago
TCRX
Tscan Therapeutics, Inc. (TCRX) Q4 Earnings Cheat Sheet
PremiumPre-EarningsTscan Therapeutics, Inc. (TCRX) Q4 Earnings Cheat Sheet
2M ago
TCRX
TScan Therapeutics announces $30M registered direct offering
Premium
The Fly
TScan Therapeutics announces $30M registered direct offering
4M ago
TCRX
TScan Therapeutics Secures $52.5M Loan from SVB
Premium
Company Announcements
TScan Therapeutics Secures $52.5M Loan from SVB
4M ago
8K
TCRX
TScan Therapeutics refinances existing convertible debt facility
PremiumThe Fly
TScan Therapeutics refinances existing convertible debt facility
4M ago
TCRX
TScan Therapeutics Announces Promising Phase 1 Trial Results
PremiumCompany Announcements
TScan Therapeutics Announces Promising Phase 1 Trial Results
5M ago
8K
TCRX
TScan Therapeutics to present data from ongoing ALLOHA Phase 1 trial at ASH
PremiumThe Fly
TScan Therapeutics to present data from ongoing ALLOHA Phase 1 trial at ASH
5M ago
TCRX
TScan Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
TScan Therapeutics Reports Q3 2024 Financial Results
5M ago
TCRX
TScan Therapeutics reports Q3 EPS (25c), consensus (29c)
PremiumThe FlyTScan Therapeutics reports Q3 EPS (25c), consensus (29c)
6M ago
TCRX
TScan Therapeutics announces preliminary results from ALLOHA Phase 1 trial
Premium
The Fly
TScan Therapeutics announces preliminary results from ALLOHA Phase 1 trial
6M ago
TCRX
TScan Therapeutics sees cash runway into 4Q26
Premium
The Fly
TScan Therapeutics sees cash runway into 4Q26
9M ago
TCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >